Ticker brief
TLRY TILRAY BRANDS INC
Consumer, Non-cyclical · Pharmaceuticals
last close
$2.81
1 day
-4.1%
14 days
-20.6%
mkt cap
$570.4M
signals 14d
39
authors 14d
30
crowd 14d
-1.0σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 64% cheap · 1 pctile own 1y | IV/HV 1.25× (as of 2026-10-13) |
| Skew — 25Δ RR 30d | -0.048 11 pctile own 1y | puts bid vs calls (downside bid) |
| Net dealer OI (NDOI) | +0.28 normal | 5-session Δ +0.09 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2025-10-08 (z=5.4) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-03 → 2026-10-14 · now -0.35 (−1 bearish … +1 bullish)
Who spoke30
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @eWhispers | A | · | 2 | +0.00 |
| @WallStDiaries | C | +0.67 | 2 | +0.00 |
| @ttvresearch | C | +1.59 | 2 | -0.30 |
| @schaeffers | C | +1.18 | 2 | +0.00 |
| @EmmanuelInvest | C | -1.12 | 2 | -0.17 |
| @wallstengine | B | -1.14 | 2 | -0.30 |
| @GetPursa | C | +0.10 | 2 | -0.30 |
| @AIStockSavvy | C | -1.05 | 2 | -0.15 |
| @PrismMarketView | C | · | 2 | +0.50 |
| @MikeFairbournCS | C | +1.09 | 1 | +0.00 |
| @vnkumarvnk | C | -1.48 | 1 | +0.00 |
| @Trading_Sunset | C | -2.68 | 1 | -0.90 |
| @SJosephBurns | C | · | 1 | +0.00 |
| @earnings_watch | B | -0.51 | 1 | +0.00 |
| @LaMonicaBuzz | B | -1.79 | 1 | +0.00 |
| @4ki4 | C | +1.04 | 1 | +0.00 |
| @TalkMarkets | C | · | 1 | -0.15 |
| @Cd_Investidores | C | -1.65 | 1 | +0.00 |
| @BenzingaSpain | C | -0.13 | 1 | +0.00 |
| @CheddaFreeze | C | +0.86 | 1 | +0.00 |
| @garcapital | C | -0.31 | 1 | +0.60 |
| @CHItrader | B | -0.22 | 1 | -0.60 |
| @DonJamesTrades | C | · | 1 | +0.00 |
| @OpenOutcrier | C | · | 1 | -0.45 |
| @financespotnews | C | +0.40 | 1 | +0.00 |
Recent signals30of 39 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-14 | @Stocksalute | -0.35 | Lists four stocks that reached all-time lows that day. | -10.5% | tweet ↗ |
| 2026-10-13 | @AIStockSavvy | -0.30 | Jefferies maintains Buy but cuts Tilray's target to $12 from $17. | -14.1% | tweet ↗ |
| 2026-10-13 | @PrismDM | +0.50 | Tilray won regulatory approval to conduct microbiological and chemical testing in-house in Portugal. | -14.1% | tweet ↗ |
| 2026-10-13 | @PrismMarketView | +0.40 | Reports regulatory approval for Tilray's EU-GMP lab to conduct in-house testing. | -14.1% | tweet ↗ |
| 2026-10-12 | @GetIrked | -0.45 | Plans another GLAS buy at 3.43 and a sell target at 8.55. — Details a new GLAS position, long-term thesis, next buy and sell targets. | -16.4% | tweet ↗ |
| 2026-10-10 | @DustinHuntwn | +0.80 | Presents five cannabis securities as 10x candidates with operating and policy catalysts. | -20.6% | tweet ↗ |
| 2026-10-08 | @d__risk | -0.55 | Summarizes expanded credit, regulatory, margin, litigation, cyber, governance, and dilution risks. | -21.7% | tweet ↗ |
| 2026-10-08 | @financespotnews | +0.00 | Tilray is scheduled to report earnings Thursday after the close. | -21.7% | tweet ↗ |
| 2026-10-08 | @ttvresearch | -0.60 | Tilray's Q1 2027 results missed both EPS and revenue estimates. | -21.7% | tweet ↗ |
| 2026-10-08 | @OpenOutcrier | -0.45 | Reports mixed Q1 results, a new 52-week low and a regulatory pause. | -21.7% | tweet ↗ |
| 2026-10-08 | @PrismMarketView | +0.60 | Tilray reported record fiscal Q1 revenue, higher profit and margins, and reduced debt. | -21.7% | tweet ↗ |
| 2026-10-08 | @EmmanuelInvest | -0.35 | Record revenue is offset by weaker profitability, cannabis contraction and roughly 10% share dilution. | -21.7% | tweet ↗ |
| 2026-10-08 | @GetPursa | -0.60 | Tilray Q1 revenue and EPS both missed expectations despite 23% annual revenue growth. | -21.7% | tweet ↗ |
| 2026-10-08 | @DonJamesTrades | +0.00 | Lists today's macro releases and notable U.S. earnings | -21.7% | tweet ↗ |
| 2026-10-08 | @CHItrader | -0.60 | Tilray missed Q1 revenue and EPS estimates despite record revenue and reaffirmed FY EBITDA guidance. | -21.7% | tweet ↗ |
| 2026-10-08 | @garcapital | +0.60 | Tilray posted record Q1 revenue of $257.1M, up 23%, and reaffirmed FY27 guidance. | -21.7% | tweet ↗ |
| 2026-10-08 | @wallstengine | -0.60 | Tilray missed Q1 revenue, EPS and EBITDA estimates while affirming below-consensus FY guidance. | -21.7% | tweet ↗ |
| 2026-10-08 | @AIStockSavvy | +0.00 | Links Tilray's Q1 2027 earnings report without reporting results. | -21.7% | tweet ↗ |
| 2026-10-08 | @schaeffers | +0.00 | Lists option-implied earnings moves for PepsiCo and Tilray. | -21.7% | tweet ↗ |
| 2026-10-08 | @GetPursa | +0.00 | Six stocks were placed on a watch list, but the tweet supplies no directional evidence. | -21.7% | tweet ↗ |
| 2026-10-08 | @CheddaFreeze | +0.00 | Provides October 8 macro-event and earnings schedule | -21.7% | tweet ↗ |
| 2026-10-08 | @BenzingaSpain | +0.00 | Lists five U.S. stocks to watch in Thursday premarket trading. | -21.7% | tweet ↗ |
| 2026-10-08 | @WallStDiaries | +0.00 | Lists three US companies reporting earnings before the Oct. 8 open. | -21.7% | tweet ↗ |
| 2026-10-07 | @Cd_Investidores | +0.00 | Lists today's macro events and premarket corporate reports | -24.4% | tweet ↗ |
| 2026-10-07 | @wallstengine | +0.00 | Lists the day's macro schedule and before-open earnings reporters. | -24.4% | tweet ↗ |
| 2026-10-07 | @EmmanuelInvest | +0.00 | Daily macro and earnings watchlist with scheduled events and consensus figures. | -24.4% | tweet ↗ |
| 2026-10-07 | @TalkMarkets | -0.15 | Frames Tilray as facing an uncertain rebound-versus-further-decline setup before earnings. | -24.4% | tweet ↗ |
| 2026-10-07 | @4ki4 | +0.00 | Lists the day's macro events and scheduled company reports. | -24.4% | tweet ↗ |
| 2026-10-07 | @LaMonicaBuzz | +0.00 | Reports Curaleaf's hostile offer for Aurora and flags Tilray's upcoming earnings. | -24.4% | tweet ↗ |
| 2026-10-07 | @schaeffers | +0.00 | Lists options-implied moves for tomorrow morning's earnings reports. | -24.4% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.